Haleon

Haleon is a multinational consumer health company headquartered in Weybridge, England. It was formed in July 2022 as a spin-off from GSK (GlaxoSmithKline). Haleon focuses on over-the-counter medicines, vitamins, minerals, and supplements, and oral health products.

History

The formation of Haleon involved the consolidation of GSK's consumer healthcare portfolio with that of Pfizer. GSK previously owned a consumer healthcare joint venture with Novartis, which GSK acquired in 2015. The combination of these assets, along with other GSK-owned brands, formed the basis of Haleon. GSK then spun off 80% of Haleon as an independent publicly traded company.

Brands

Haleon owns and markets a wide range of well-known consumer healthcare brands, including:

• Sensodyne (toothpaste for sensitive teeth)
• Panadol (pain relief)
• Advil (pain relief)
• Theraflu (cold and flu remedies)
• Centrum (multivitamins)
• Voltaren (topical pain relief)
• ChapStick (lip balm)

Operations

Haleon operates globally, with a presence in numerous countries and regions. Its products are sold through various channels, including pharmacies, supermarkets, and online retailers.

Governance

Haleon is led by a board of directors and a management team. The company is listed on the London Stock Exchange (LSE).